NEW YORK, June 11 /PRNewswire-FirstCall/ -- On June 8, Lloyd H. Malchow, CEO of SenoRx, Inc. updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company and its target markets, recent press releases, current capitalization, and upcoming strategic and financial milestones for investors to watch for.
(http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO )
To hear the interview in its entirety, visit http://www.wallst.net, and click on “Interviews.” The interview can be accessed either by locating the company’s ticker symbol under the appropriate exchange on the left-hand column of the “Interviews” section of the site, or by entering the company’s ticker symbol in the Search Archive window.
About SenoRx
SenoRx , which completed its initial public offering of common stock in March 2007, develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis of breast cancer. SenoRx’s field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. With 17 products that have already received FDA 510(k) clearance across the continuum of breast care, SenoRx is developing additional minimally invasive products for diagnosis and treatment of breast cancer. For more information, visit the company’s website at http://www.senorx.com.
About WallSt.net:
http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. http://www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid- sized publicly traded companies. We are expecting to receive two hundred eighty dollars from SenoRx, Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGOPRN Photo Desk, photodesk@prnewswire.comWallSt.net
CONTACT: Nick Iyer of Digital Wall Street, Inc., 1-800-4-WALL-ST
